DB
Deepika Bhatia
About Deepika Bhatia
Data last updated:
Deepika Bhatia is a Director at Biocell Pharmaceuticals Private Limited (since 2025) and Director at Biocordis Pharmaceuticals Private Limited (since 2025). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹4.78 Cr; the largest is Biocell Pharmaceuticals Private Limited at ₹3.81 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Feb 2025 | 2011 | ₹3.81 Cr (FY 2025) | Active | |
| Director | 07 Feb 2025 | 2011 | ₹97.5 Lakh (FY 2025) | Active |
Board colleagues of Deepika Bhatia
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anurag Bhatia | 02397243 | Biocell Pharmaceuticals Private Limited , Biocordis Pharmaceuticals Private Limited | Director |
| Karam Singh Babra | 03612866 | Biocordis Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deepika Bhatia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deepika Bhatia
Deepika Bhatia currently holds 2 directorships: Biocell Pharmaceuticals Private Limited (Director, since 07 Feb 2025, revenue ₹3.81 Cr (FY 2025)); Biocordis Pharmaceuticals Private Limited (Director, since 07 Feb 2025, revenue ₹97.5 Lakh (FY 2025)).
Deepika Bhatia was first appointed on 07 Feb 2025 as Director at Biocell Pharmaceuticals Private Limited.
The 2 current companies of Deepika Bhatia that report revenue have a combined latest revenue of ₹4.78 Cr: Biocell Pharmaceuticals Private Limited ₹3.81 Cr (FY 2025); Biocordis Pharmaceuticals Private Limited ₹97.5 Lakh (FY 2025).
The current boards of Deepika Bhatia's companies include Anurag Bhatia (Biocell Pharmaceuticals Private Limited), Karam Singh Babra (Biocordis Pharmaceuticals Private Limited).